Summary
WASHINGTON -- Using a new sophisticated test, the Food and Drug Administration has found a "contaminant" in 5 percent to 20 percent of samples of the blood thinner heparin distributed by Baxter International, agency officials said Wednesday. They increased the reported number of patients who might have died from allergic reactions to the drug from four to 19.
FDA Chief Medical Officer Janet Woodcock said the agency is investigating whether the contaminant, a large molecule similar to heparin, was produced as part of faulty manufacturing or whether it was intentionally added to reduce costs.See the full content of this document
Extract
'Contaminant' Found in Heparin
The active ingredient for much of the heparin used in the United States comes from China, and the Baxter product ca...
See the full content of this document
Sponsored links
